RBC Capital analyst Ben Hendrix raised the firm’s price target on HCA Healthcare to $315 from $283 and keeps an Outperform rating on the shares. The company’s Q1 earnings beat was highlighted by solid volume growth across all categories and continued labor improvement, setting a solid tone for provider earnings, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HCA:
- HCA Healthcare price target raised to $310 from $280 at Deutsche Bank
- HCA Healthcare price target raised to $320 from $285 at Loop Capital
- HCA Healthcare price target raised to $326 from $292 at TD Cowen
- HCA Healthcare price target raised to $323 from $294 at BofA
- HCA Healthcare price target raised to $320 from $300 at Raymond James
